Ignota Labs
London
About Ignota Labs
Ignota Labs recognizes that safety errors during the drug discovery process can result in expensive setbacks and delays in bringing life-changing medications to market. Ignota Labs world leading AI methods, which include deep learning and machine learning approaches, are intended to examine complicated molecular data and provide accurate toxicity predictions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $6.9M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
- Website: ignotalabs.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ignota-labs-31730 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.